The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

X will start adding parody labels to accounts and posts as the company tries to add some form of transparency to the platform ...

Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...

Boston-area startup Mediar Therapeutics is teaming up with Eli Lilly on a new drug for idiopathic pulmonary fibrosis. Lilly — one of the five large pharmas backing Mediar – will pay ...